NYSE:WST - West Pharmaceutical Services Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$103.67 -3.14 (-2.94 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$103.67
Today's Range$103.52 - $106.85
52-Week Range$82.74 - $125.09
Volume218,781 shs
Average Volume410,548 shs
Market Capitalization$7.69 billion
P/E Ratio36.89
Dividend Yield0.56%
Beta1.25
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company has a development agreement with scPharmaceuticals Inc. for the development of FUROSCIX, a treatment of edema in patients with heart failure. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 billion
Cash Flow$4.1435 per share
Book Value$18.85 per share

Profitability

Net Income$206.90 million

Miscellaneous

Employees7,700
Market Cap$7.69 billion
Next Earnings Date4/25/2019 (Estimated)
OptionableOptionable

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Friday, February 22nd. Shareholders of record on Wednesday, April 17th will be paid a dividend of $0.15 per share on Wednesday, May 1st. This represents a $0.60 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend is Tuesday, April 16th. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services declared that its board has approved a stock repurchase program on Thursday, February 15th 2018, which permits the company to buyback 800,000 outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's management believes its shares are undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) announced its earnings results on Thursday, February, 14th. The medical instruments supplier reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.72 by $0.01. The medical instruments supplier had revenue of $422.50 million for the quarter, compared to analyst estimates of $432.38 million. West Pharmaceutical Services had a net margin of 12.05% and a return on equity of 15.89%. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the firm earned $0.64 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY19 earnings guidance on Thursday, February, 14th. The company provided EPS guidance of $2.77-2.89 for the period, compared to the Thomson Reuters consensus estimate of $3.12. The company issued revenue guidance of $1.795-1.820 billion, compared to the consensus revenue estimate of $1.84 billion.West Pharmaceutical Services also updated its FY 2019 guidance to $2.77-2.89 EPS.

What price target have analysts set for WST?

1 equities research analysts have issued 1-year price objectives for West Pharmaceutical Services' stock. Their predictions range from $85.00 to $85.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $85.00 in the next year. This suggests that the stock has a possible downside of 18.0%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

Press coverage about WST stock has been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. West Pharmaceutical Services earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Johnson & Johnson (JNJ), Walmart (WMT), Alibaba Group (BABA), Veeva Systems (VEEV), Biogen (BIIB), Pfizer (PFE) and Micron Technology (MU).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP of Global Operations & Supply Chain (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.37%), Oregon Public Employees Retirement Fund (3.83%), WCM Investment Management LLC (1.50%), Fisher Asset Management LLC (1.25%), 1832 Asset Management L.P. (1.19%) and Bank of New York Mellon Corp (1.10%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which major investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Victory Capital Management Inc., Bank of New York Mellon Corp, Bank of America Corp DE, Eaton Vance Management, Retirement Systems of Alabama, Riverbridge Partners LLC and Mawer Investment Management Ltd.. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone, Karen Flynn and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.

Which major investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, BlackRock Inc., First Trust Advisors LP, Millennium Management LLC, Massachusetts Financial Services Co. MA, Lord Abbett & CO. LLC and Geode Capital Management LLC. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $103.67.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $7.69 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  182 (Vote Outperform)
Underperform Votes:  298 (Vote Underperform)
Total Votes:  480
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel